A. Romero

发表

Tea and Atherosclerosis

W. Young, ROBERT L. Hotovec, A. Romero, 1967, Nature.

Characterization of U-92016A as a selective, orally active, high intrinsic activity 5-hydroxytryptamine1A agonist.

M. Piercey, R. Mccall, M. Bienkowski, 1994, The Journal of pharmacology and experimental therapeutics.

IL-13-induced airway mucus production is attenuated by MAPK13 inhibition.

M. Holtzman, D. Byers, Anand C Patel, 2012, The Journal of clinical investigation.

Synthesis of an Azasteroid Using an Acyl Iminium Ion-Initiated Tandem Cyclization.

S. Mizsak, J. Leiby, A. Romero, 1996, The Journal of organic chemistry.

OXIDATIVE CYCLIZATION OF ACYCLIC UREAS WITH BIS(TRIFLUOROACETOXY)IODOBENZENE TO GENERATE N-SUBSTITUTED 2-BENZIMIDAZOLINONES

E. Jacobsen, J. Mickelson, A. Romero, 1996 .

Synthesis of the Selective D2 Receptor Agonist PNU-95666E from d-Phenylalanine Using a Sequential Oxidative Cyclization Strategy

A. Romero, M. W. McMillan, W. Darlington, 1997 .

Oxidative Cyclization of Acyclic Ureas with Bis(trifluoroacetoxy) iodobenzene to Generate N‐Substituted 2‐Benzimidazolinones.

E. Jacobsen, J. Mickelson, A. Romero, 1996 .

Synthesis of optically active isoquinuclidines utilizing a diastereoselectivity control element

B. Trost, A. Romero, 1986 .

Chapter 3. Advances in Central Serotoninergics

R. Mccall, A. Romero, 1992 .

High-Throughput Screening Normalized to Biological Response

William C. Nolan, M. Holtzman, Anand C Patel, 2014, Journal of biomolecular screening.

Asymmetric Synthesis of the C3alpha Fragment of 5,6-Dihydro-alpha-pyrone Nonpeptidic HIV-1 Protease Inhibitors.

D. Romero, Fusen Han, A. Romero, 1999, The Journal of organic chemistry.

Substituted 4-aminopiperidines having high in vitro affinity and selectivity for the cloned human dopamine D4 receptor.

M. Smith, T. Poel, D. Dinh, 1997, European journal of pharmacology.

The crystal structure of phosphorylated MAPK13 reveals common structural features and differences in p38 MAPK family activation.

M. Holtzman, S. Scheaffer, T. Brett, 2015, Acta crystallographica. Section D, Biological crystallography.

Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo.

A. Carlsson, L. J. King, K. Svensson, 1993, Journal of medicinal chemistry.

Model for the polyepoxide cyclization route to polyether antibiotics

W. C. Still, A. Romero, 1986 .

Self-cleavage of Human CLCA1 Protein by a Novel Internal Metalloprotease Domain Controls Calcium-activated Chloride Channel Activation*♦

C. Nichols, M. Holtzman, S. Scheaffer, 2012, The Journal of Biological Chemistry.

A new MAPK13-guided inhibitor for respiratory inflammation and mucus production

Shamus P. Keeler, S. Brody, M. Holtzman, 2023, bioRxiv.

First comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes.

M. Holtzman, Dhara A. Patel, D. Kober, 2016, Biochimica et biophysica acta.

Novel 2-substituted tetrahydro-3H-benz[e]indolamines: highly potent and selective agonists acting at the 5-HT1A receptor as possible anxiolytics and antidepressants.

M. Piercey, R. Mccall, M. Smith, 1993, Journal of medicinal chemistry.

Epithelial-Immune Cell Interactions for Drug Discovery in Chronic Obstructive Pulmonary Disease.

Shamus P. Keeler, Xinyu Wang, M. Holtzman, 2018, Annals of the American Thoracic Society.

A potent MAPK13–14 inhibitor prevents airway inflammation and mucus production

Shamus P. Keeler, S. Brody, M. Holtzman, 2023, bioRxiv.